Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00326092 |
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma Ocular Hypertension |
Drug: Brinzolamide/Timolol |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | C-05-49 |
Study First Received: | May 12, 2006 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00326092 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Carbonic Anhydrase Inhibitors Brinzolamide Glaucoma Eye Diseases Glaucoma, Open-Angle |
Vascular Diseases Timolol Hypertension Ocular Hypertension |
Carbonic Anhydrase Inhibitors Molecular Mechanisms of Pharmacological Action Brinzolamide Glaucoma Eye Diseases Glaucoma, Open-Angle |
Vascular Diseases Enzyme Inhibitors Cardiovascular Diseases Pharmacologic Actions Ocular Hypertension Hypertension |